Want to see AU:LYL full AI Analyst Report?
Lycopodium Limited (LYL) AI Stock Analysis
Lycopodium Limited
(ASX:LYL)
The overall score is driven primarily by Lycopodium’s strong financial profile—profitable growth, a low‑risk balance sheet and increasingly reliable cash generation—supported by a very positive earnings call featuring record results and confidence in substantial FY‑27 growth from a well‑funded pipeline. Technicals add to the constructive picture with a clear uptrend, though elevated momentum readings suggest the share price has already moved strongly, while the current mid‑20s P/E and modest yield indicate a fair, growth‑backed valuation rather than a bargain, collectively placing the stock in a solid but not extreme upper‑tier range.
Lycopodium Limited (LYL) vs. iShares MSCI Australia ETF (EWA)
- Market Cap
- AUD 557.99M
- Dividend Yield
- 2.95%
- Average Volume (3M)
- 101.14K
- Price to Earnings (P/E)
- 19.4
- Beta (1Y)
- 0.52
- Revenue Growth
- 12.00%
- EPS Growth
- -5.39%
- Country
- Australia
- Employees
- 1,300
- Sector
- Industrials
- Sector Strength
- 63
- Industry
- Engineering & Construction
Lycopodium Limited Business Overview & Revenue Model
Company Description
Established in 1992 and based in East Perth, Australia, Lycopodium Limited provides expert engineering and complete project execution solutions across the natural resources, infrastructure, and industrial manufacturing sectors. The company operates t...
How the Company Makes Money
Lycopodium Limited makes money by providing professional services for major capital projects, typically in the resources (mining and minerals processing) value chain. Revenue is primarily generated through contracted project and engineering services,...
Lycopodium Limited Earnings Call Summary
The call presents a strongly positive operational and financial picture: record revenue, solid margins hitting NPAT targets, robust cash and equity growth, and an expanding project and study pipeline with early and confident FY'27 guidance. Key achievements include numerous project awards, a growing Americas footprint and substantial increases in committed contracts and studies. Primary risks flagged are execution and sovereign risks in foreign jurisdictions, about 30% of FY'27 revenue still uncommitted, capacity constraints to meet demand (requiring further hiring and office expansion), and regional concentration (58% revenue from Africa). On balance, the highlights substantially outweigh the lowlights, though execution of the strong pipeline remains critical to realize guidance.
Q4-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Lycopodium has brought forward FY‑27 guidance of AUD 540–580m revenue (midpoint AUD 560m, roughly +50% on FY‑26 revenue of $377.5m) and NPAT of $54–58m (consistent with its ~±10% NPAT margin target); management says just under 70% of FY‑27 revenue is already locked in (within ~AUD 661m of committed contracts), with >90 studies in the pipeline and six‑month momentum metrics including committed contracts +59%, revenue opportunity pipeline +8%, managed CapEx +32% and studies up twofold—backed by FY‑26 results of EBITDA $59.5m (15.7%), PBT $52.5m, NPAT $40.2m (10.6%), EPS $1.01, equity $170.7m (+13%), ROE 25%, cash $106.2m, NTA $3.92/share and minimal debt.
Lycopodium Limited Financial Statement Overview
Summary
Strong multi‑year revenue growth, consistently double‑digit profit margins, a conservative balance sheet with rising equity and falling leverage, and improving, cash‑backed earnings support a high score, partly offset by recent margin compression and volatile free‑cash‑flow growth reflecting project‑timing risk.
Income Statement
80PositiveBalance Sheet
88Very PositiveCash Flow
82Very Positive| Breakdown | TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 374.02M | 374.02M | 333.94M | 344.55M | 323.88M | 228.71M |
| Gross Profit | 71.10M | 71.10M | 307.69M | 312.49M | 80.35M | 42.38M |
| EBITDA | 52.54M | 53.83M | 67.82M | 74.55M | 70.48M | 45.64M |
| Net Income | 40.17M | 40.17M | 42.22M | 50.71M | 46.78M | 27.18M |
Balance Sheet | ||||||
| Total Assets | 296.92M | 296.92M | 241.08M | 217.04M | 219.83M | 224.12M |
| Cash, Cash Equivalents and Short-Term Investments | 106.19M | 106.19M | 79.67M | 68.19M | 82.41M | 100.95M |
| Total Debt | 12.49M | 12.49M | 16.42M | 12.33M | 15.70M | 16.65M |
| Total Liabilities | 126.25M | 126.25M | 90.61M | 89.60M | 106.87M | 124.45M |
| Stockholders Equity | 169.94M | 169.94M | 151.87M | 128.06M | 114.64M | 100.50M |
Cash Flow | ||||||
| Free Cash Flow | 59.29M | 59.29M | 35.24M | 26.76M | 15.38M | 37.72M |
| Operating Cash Flow | 61.75M | 61.75M | 37.21M | 27.84M | 19.79M | 41.68M |
| Investing Cash Flow | -8.23M | -8.23M | -922.21K | 1.26M | -4.45M | 655.17K |
| Financing Cash Flow | -25.45M | -25.45M | -24.76M | -40.38M | -34.05M | -18.51M |
Lycopodium Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:LYL, the sentiment is Negative. The current price of 19.98 is below the 20-day moving average (MA) of 21.61, below the 50-day MA of 22.00, and above the 200-day MA of 16.92, indicating a neutral trend. The MACD of -0.67 indicates Positive momentum. The RSI at 37.88 is Neutral, neither overbought nor oversold. The STOCH value of 37.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:LYL.
Lycopodium Limited Peers Comparison
Overall Rating
- AU:LYL81.9Outperform
AU:GNG76Outperform
AU:MND72Outperform
AU:NWH70Outperform
AU:CVL60Neutral
AU:DOW55Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| AU:LYL | 82Outperform | AUD 788.25M | 19.40 | 24.65% | 2.95% | 12.00% | -5.39% |
| AU:GNG | 76Outperform | AUD 1.34B | 30.57 | 53.12% | 3.70% | 2.95% | 12.85% |
| AU:MND | 72Outperform | AUD 2.96B | 23.16 | 22.77% | 3.67% | 29.43% | 50.05% |
| AU:NWH | 70Outperform | AUD 2.91B | 18.53 | 23.03% | 3.65% | 31.39% | 451.49% |
| Sector * | 63Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
| AU:CVL | 60Neutral | AUD 867.75M | 16.73 | 9.25% | 3.56% | 11.40% | 22.22% |
| AU:DOW | 55Neutral | AUD 4.65B | 21.64 | 11.01% | 4.09% | -7.37% | 59.81% |
* Industrials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| AU:LYL | Lycopodium Limited | 19.98 | 7.88 | 65.14% | |
| AU:DOW | Downer EDI Limited | 7.14 | -0.27 | -3.58% | |
| AU:MND | Monadelphous Group Limited | 29.41 | 7.28 | 32.89% | |
| AU:NWH | NRW Holdings Limited | 6.30 | 1.64 | 35.22% | |
| AU:GNG | GR Engineering Services Ltd | 7.03 | 3.57 | 103.41% | |
| AU:CVL | Civmec Singapore Limited Shs Chess Deposit Interests Repr 1 Sh | 1.70 | 0.32 | 23.01% |
Lycopodium Limited Corporate Events
Lycopodium Sets November AGM, Moves to Digital Investor Communications
Lycopodium Limited has scheduled its Annual General Meeting for 12 November 2026 in East Perth, Western Australia, inviting shareholders to participate in person or via proxy voting. The company is moving away from routine hard-copy mailings of the N...
Lycopodium Director Karl Cicanese Cuts Ordinary Shareholding in On-Market Sale
Lycopodium Limited reported a change in the shareholding of director Karl Cicanese, reflecting an update to his relevant interests in the company’s securities as required under ASX listing rules. The disclosure underscores the company’s a...
Lycopodium Sets November Date for 2026 Annual General Meeting
Lycopodium Limited has scheduled its next Annual General Meeting to be held in Perth at 10:30am AWST on 12 November 2026, in line with ASX listing requirements and its corporate constitution. The company has set 9 October 2026 as the deadline for wri...
Lycopodium Wins A$42.9m EP Contract for Major Côte d’Ivoire Gold Project
Lycopodium Limited has secured an approximately A$42.9 million Engineering and Procurement services contract from Endeavour Mining for the Assafo-Dibibango Gold Project in Côte d’Ivoire. The mandate covers a 5.0 Mtpa carbon-in-leach proces...
Lycopodium Wins A$49.4m EPCM Mandate for Greatland’s Havieron Project
Lycopodium Limited has secured a A$49.4 million Engineering, Procurement and Construction Management contract from Greatland Resources for the preproduction phase of the Havieron gold-copper project in Western Australia. Acting as project delivery pa...
Lycopodium Director Bruno Ruggiero Cuts Indirect Shareholding in $7.8m Trade
Lycopodium Limited has reported a significant change in the indirect shareholding of director Bruno Ruggiero, as disclosed to the ASX under listing rule obligations. His interests are held through entities Luala Pty Ltd and Ziziphus Pty Ltd, reflecti...
Lycopodium Director Partially Reduces Shareholding in On-Market Trade
Lycopodium Limited has disclosed a change in the shareholding of managing director Peter De Leo, who has reduced his indirect interest in the company by selling 200,000 fully paid ordinary shares on market. Following the transaction, conducted via en...
Lycopodium Director Reduces Indirect Shareholding by 200,000 Shares
Lycopodium Limited has reported a change in the shareholding of director Rodney Lloyd Leonard, reflecting an adjustment in his indirect equity position in the company via the Leonard Family Trust. Such director dealings are closely watched by investo...
Lycopodium sets out compliance with ASX corporate governance standards
Lycopodium Limited has detailed its corporate governance framework, confirming broad compliance with the ASX Corporate Governance Council’s fourth edition Principles and Recommendations. The Board aims to safeguard the interests of shareholders...
Lycopodium Files ASX Appendix 4G, Confirms Governance Compliance
Lycopodium Limited has lodged its Appendix 4G and corporate governance statement for the year ended 30 June 2026, confirming that its key governance disclosures are available on its website rather than solely in the annual report. The statement, appr...
Lycopodium lifts dividend on solid FY26 and eyes record year with expanding global project pipeline
Lycopodium reported FY26 revenue of $377.5 million and NPAT of $40.2 million, both within prior guidance, and declared a fully franked full-year dividend of 59 cents per share, up 69% on FY25, supported by a cash balance of $106.2 million. The compan...
Lycopodium lifts dividends as revenue climbs and expands via SAXUM acquisition
Lycopodium reported an 11.2% rise in revenue from ordinary activities to A$377.6 million for the year to 30 June 2026, but profit after tax attributable to members declined 4.9% to A$40.2 million. Despite the softer earnings, the board lifted total d...
Lycopodium Wins A$93m EPCM Mandate for Blackwater Mine Expansion
Lycopodium Limited has secured a A$93 million engineering, procurement and construction management contract for Artemis Gold’s Expanded Phase 2 project at the Blackwater Mine in British Columbia, Canada. The win builds on Lycopodium’s exi...
Lycopodium wins A$22m Pilgangoora lithium expansion engineering contract
Lycopodium Limited has secured a detailed engineering services contract worth about A$22 million from Pilgangoora Operations Pty Ltd, a subsidiary of PLS Group, to design the Wet Plant for the proposed P2000 Expansion Project at the Pilgangoora lithi...
Lycopodium sets 19 August date for FY26 results and investor webinar
Lycopodium Limited has announced it will release its full-year results for the period ended 30 June 2026 on 19 August 2026, reinforcing its communication schedule with investors and the market. The disclosure date provides stakeholders with clear tim...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 21, 2026